They are involved in metabolic processes and, in this way, they are responsible for maintenance of health
Remember: 1 milligram (mg) = 1000 micrograms (mcg)
A 2020 retrospective study of 6,228 women using spironolactone for up to 8 years found no increased risk of breast cancer, hyperkalemia requiring hospitalization, or renal impairment compared to matched controls 11
& Teixeira, A
[PubMed Central ID: PMC5069735]
The incidence varies considerably between different medications and doses: Semaglutide (Ozempic): Vomiting occurs in approximately 5-10% of patients at diabetes doses Semaglutide (Wegovy): At the higher weight management dose (2.4mg), vomiting affects up to 16% of patients Liraglutide (Victoza): Vomiting affects approximately 5% of patients Liraglutide (Saxenda): At weight management doses, vomiting occurs in about 7-10% of patients Dulaglutide (Trulicity): Vomiting affects approximately 7-9% of patients Tirzepatide (Mounjaro): Vomiting occurs in approximately 5-10% of patients, varying by dose These side effects are most pronounced during the initial treatment phase, particularly in the first 48 weeks, and often diminish as the body adapts to the medication
